UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 


FORM 8-K
 


CURRENT REPORT PURSUANT TO SECTION 13 OR 15 (d)
OF THE SECURITIES EXCHANGE ACT OF 1934
 
Date of Report:  June 22, 2021
(Date of earliest event reported)

INTERNATIONAL BUSINESS MACHINES CORPORATION
(Exact name of registrant as specified in its charter)



New York
 
1-2360
 
13-0871985
(State of Incorporation)
 
(Commission File Number)
 
(IRS Employer Identification No.)
         
 One New Orchard Road    
Armonk, New York
 
10504
(Address of principal executive offices)
 
(Zip Code)
 
914-499-1900
(Registrant’s telephone number)



Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each class
 
Trading symbol(s)
 
Name of each exchange
on which registered
Capital stock, par value $.20 per share
 
IBM
 
New York Stock Exchange
Capital Stock, par value $.20 per share
 
IBM
  NYSE Chicago
0.500% Notes due 2021
 
IBM 21B
 
New York Stock Exchange
2.625% Notes due 2022
 
IBM 22A
 
New York Stock Exchange
1.250% Notes due 2023
 
IBM 23A
 
New York Stock Exchange
0.375% Notes due 2023
 
IBM 23B
 
New York Stock Exchange
1.125% Notes due 2024
 
IBM 24A
 
New York Stock Exchange
2.875% Notes due 2025
 
IBM 25A
 
New York Stock Exchange
0.950% Notes due 2025
 
IBM 25B
 
New York Stock Exchange
0.875% Notes due 2025
 
IBM 25C
 
New York Stock Exchange
0.300% Notes due 2026
 
IBM 26B
 
New York Stock Exchange
1.250% Notes due 2027
 
IBM 27B
 
New York Stock Exchange
0.300% Notes due 2028
 
IBM 28B
 
New York Stock Exchange
1.750% Notes due 2028
 
IBM 28A
 
New York Stock Exchange
1.500% Notes due 2029
 
IBM 29
 
New York Stock Exchange
1.750% Notes due 2031
 
IBM 31
 
New York Stock Exchange
0.650% Notes due 2032
 
IBM 32A
 
New York Stock Exchange
1.200% Notes due 2040
 
IBM 40
 
New York Stock Exchange
7.00% Debentures due 2025
 
IBM 25
 
New York Stock Exchange
6.22% Debentures due 2027
 
IBM 27
 
New York Stock Exchange
6.50% Debentures due 2028
 
IBM 28
 
New York Stock Exchange
7.00% Debentures due 2045
 
IBM 45
 
New York Stock Exchange
7.125% Debentures due 2096
 
IBM 96
 
New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.



Item 1.01. Entry into a Material Definitive Agreement.

On June 22, 2021, International Business Machines Corporation (“IBM”) (i) entered into a new $2.5 billion Three-Year Credit Agreement (the “New Three-Year Credit Agreement”) with the several banks and other financial institutions from time to time party thereto (the “Three-Year Lenders”) and (ii) entered into a new $7.5 billion Five-Year Credit Agreement (the “New Five-Year Credit Agreement” and, together with the Three-Year Credit Agreement, the “New Credit Agreements”) with the several banks and other financial institutions from time to time party thereto (the “Five-Year Lenders” and, together with the Three-Year Lenders, the “Lenders”).

The New Three-Year Credit Agreement replaces IBM’s existing Amended and Restated Three-Year Credit Agreement, dated as of July 19, 2018 (as amended, supplemented or otherwise modified from time to time, the “Existing Three-Year Credit Agreement”), among IBM, the several banks and other financial institutions from time to time parties thereto, JPMorgan Chase Bank, N.A., as Administrative Agent, BNP Paribas, Citibank, N.A., Royal Bank of Canada and Mizuho Bank, Ltd., as Syndication Agents, and the Documentation Agents named therein. The New Three-Year Credit Agreement expires, unless extended, on June 21, 2024, and the Existing Three-Year Credit Agreement was scheduled to expire on July 20, 2023.  The New Five-Year Credit Agreement replaces IBM’s existing Amended and Restated Five-Year Credit Agreement, dated as of July 19, 2018 (as amended, supplemented or otherwise modified from time to time, the “Existing Five-Year Credit Agreement”), among IBM, the Subsidiary Borrowers (as defined in the Existing Five-Year Credit Agreement) parties thereto, the several banks and other financial institutions from time to time parties thereto, JPMorgan Chase Bank, N.A., as Administrative Agent, BNP Paribas, Citibank, N.A., Royal Bank of Canada and Mizuho Bank, Ltd., as Syndication Agents, and the Documentation Agents named therein.  The New Five-Year Credit Agreement expires, unless extended, on June 22, 2026, and the Existing Five-Year Credit Agreement was scheduled to expire on July 20, 2024.

Also on June 22, 2021, in connection with entering into the New Credit Agreements, IBM terminated the revolving credit commitments under the 364-Day Credit Agreement, dated as of July 2, 2020 (as amended, supplemented or otherwise modified from time to time, the “Existing 364-Day Credit Agreement”), among IBM, the several banks and other financial institutions from time to time parties thereto, JP Morgan Chase Bank, N.A., as Administrative Agent, BNP Paribas, Citibank N.A., Royal Bank of Canada and Mizuho Bank, Ltd., as Syndication Agents, and the Documentation Agents named therein.  The Existing 364-Day Credit Agreement was scheduled to expire on July 1, 2021.

The New Credit Agreements permit IBM and its Subsidiary Borrowers (if any) to borrow up to an aggregate of $10.0 billion on a revolving basis.  Borrowings of any Subsidiary Borrowers will be unconditionally guaranteed by IBM under each of the New Credit Agreements.  Subject to certain conditions stated in each New Credit Agreement, IBM and the Subsidiary Borrowers may borrow, prepay and re-borrow amounts under each New Credit Agreement at any time during the term of the applicable New Credit Agreement.  Funds borrowed may be used for the general corporate purposes of IBM and its subsidiaries.  Interest rates on borrowings under the New Credit Agreements will be based on prevailing market rates, plus a margin, as further described in the New Credit Agreements.  The New Credit Agreements contain customary representations and warranties, covenants, events of default and indemnification provisions.   This summary description of the New Credit Agreements does not purport to be complete and is qualified in its entirety by reference to the full text of the New Credit Agreements, which are filed as Exhibits 10.1 and 10.2 to this report, and are incorporated by reference herein.

In the ordinary course of their respective businesses, the Lenders and their affiliates have engaged, and may in the future engage, in commercial banking, investment banking, financial advisory or other services with IBM and/or its subsidiaries for which they have in the past and/or may in the future receive customary compensation and expense reimbursement. 

Item 1.02. Termination of a Material Definitive Agreement. 

The information set forth in Item 1.01 of this Current Report on Form 8-K is incorporated by reference herein. 

Item 2.03. Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. 

The information set forth in Item 1.01 of this Current Report on Form 8-K is incorporated by reference herein. 

Item 9.01. Financial Statements and Exhibits.

 (d) Exhibits 

Exhibit No.
 
 
Description


104
 
Cover Page Interactive Data File (embedded within the Inline XBRL Document)


SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
 
 Date:  June 25, 2021
 
 
 
 
 
 
 
 
By:
/s/ Simon J. Beaumont
 
 
 
Simon J. Beaumont
Vice President and Treasurer